MCR - Immunosep

PERSONALIZED IMMUNOTHERAPY IN SEPSIS: A MULTICENTRE AND MULTINATIONAL, DOUBLE-BLIND, DOUBLE-DUMMY RANDOMIZED CLINICAL TRIAL (THE IMMUNOSEP TRIAL)

PHASE

II

NCT Number

NCT04990232

DEFINITION

Device POST-CE Mark

SPONSOR

Hellenic Institute for the Study of Sepsis